Authors: Ria Arnold, Bruce A. Pussell, Timothy J. Pianta, Virginija Grinius, Cindy S-Y. Lin, Matthew C. Kiernan, James Howells, Meg J. Jardine, Arun V. Krishnan
DOI: 10.1371/journal.pone.0059055
Abstract Summary
Hemodiafiltration (HDF) shows promise for managing peripheral neuropathy in end-stage kidney disease patients. This study found nerve excitability measures were significantly closer to normal in HDF-treated patients compared to high-flux hemodialysis, both during single sessions and over 18 months. These findings suggest HDF may better preserve nerve function in dialysis patients.
Why Brain? ðŸ§
Hemodiafiltration maintains nerve function closer to normal compared to high-flux hemodialysis in kidney failure patients, offering a promising approach to prevent peripheral neuropathy complications.
The image is AI-generated for illustrative purposes only. Courtesy of Midjourney.
